Streptococcus milleri group

(redirected from Streptococcus anginosus group)

Strep·to·coc·cus mil·ler·i group

(strep'tō-kok'ŭs mil'ler-ī grūp)
A term used to refer to the Streptococcus intermedius group, which contains three distinct streptococcal species: S. intermedius, S. constellatus, and S. anginosus. These bacteria are found in the human oral cavity and have been associated with a variety of infections including bacteremia, endocarditis, and central nervous system, oral, and thoracic infections.
References in periodicals archive ?
INDICATION AND USAGE DALVANCE (dalbavancin) for injection is indicated for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible isolates of the following Gram-positive microorganisms: Staphylococcus aureus (including methicillin-susceptible and methicillin-resistant strains),Streptococcus pyogenes, Streptococcus agalactiae, and Streptococcus anginosus group (including S.
Genotyping by amplified fragment length polymorphism analysis reveals persistence and recurrence of infection with Streptococcus anginosus group organisms.
The association of the Streptococcus anginosus group (SAG) of bacteria with the tendency to form local suppurative infections has long been recognized, and these organisms are the most common pathogens associated with bacterial intracerebral abscesses (1-4).
Culture-negative intracerebral abscesses in children and adolescents from Streptococcus anginosus group infection: a case series.
Indications TYGACIL(R) (tigecycline) is indicated for the treatment of adults with: -- Complicated skin and skin structure infections caused by Escherichia coli, Enterococcus faecalis (vancomycin-susceptible isolates only), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus agalactiae, Streptococcus anginosus group (includes S.
INDICATION AND USAGE DALVANCE (dalbavancin) for injection is indicated for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible isolates of the following Gram-positive microorganisms: Staphylococcus aureus(including methicillin-susceptible and methicillin-resistant strains),Streptococcus pyogenes, Streptococcus agalactiae, and Streptococcus anginosus group (including S.
Complicated skin and skin structure infections (cSSSI) caused by Escherichia coli, Enterococcus faecalis (vancomycin-susceptible isolates), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus agalactiae, Streptococcus anginosus group (includes S.
Complicated intra-abdominal infections (cIAI) caused by Citrobacter freundii, Enterobacter cloacae, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Enterococcus faecalis (vancomycin-susceptible isolates), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus anginosus group (includes S.
Complicated skin and skin structure infections (cSSSI) caused by Escherichia coli, Enterococcus faecalis (vancomycin-susceptible isolates only), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus agalactiae, Streptococcus anginosus group (includes S.